39 research outputs found
Seroprevalence of antibodies to measles, mumps, and rubella, and serologic responses after vaccination among human immunodeficiency virus (HIV)-1 infected adults in Northern Thailand
High prevalence of lipoatrophy in pre-pubertal South African children on antiretroviral therapy: a cross-sectional study
Haematological changes after switching from stavudine to zidovudine in HIV-infected children receiving highly active antiretroviral therapy
APOBEC3G and G-to-A hypermutation in Asian children with different HIV/AIDS disease progression
Efavirenz concentrations and probability of HIV replication in children
In 188 HIV-infected children receiving efavirenz, a lower mid-dose (C-12) was associated with a higher risk of HIV-1 viral load >400 copies/mL (P = 0.03). Simulations for a normalized population receiving US Food and Drug Administration weight-band dosing predicted that 15% of children would have a C-12 below target threshold (<1.0mg/L) with a 23% risk of viral replication
Outcomes of Antiretroviral Therapy in Children in Asia and Africa: A Comparative Analysis of the IeDEA Pediatric Multiregional Collaboration
Please help populate SUNScholar with the full text of SU research output. Also - should you need this item urgently, please send us the details and we will try to get hold of the full text as quick possible. E-mail to [email protected]. Thank you.Journal Articles (subsidised)Geneeskunde en GesondheidswetenskappePediatrie En Kindergesondhei
Poor Cognitive Functioning of School-Aged Children in Thailand with Perinatally Acquired HIV Infection Taking Antiretroviral Therapy
Neurocognitive outcome is an essential aspect of treatment for HIV-infected children. This study is aimed at assessing cognitive functioning in school-aged HIV-infected children and the change after receiving antiretroviral therapy (ART). We conducted a prospective cohort study of HIV-infected Thai children from 6â12 years of age compared with HIV-affected (children of HIV-positive mothers who were not infected with HIV), and normal control groups. Wechsler Intelligence Scale for Children-III (WISC-III) was administered at enrollment and 30 months of follow-up. Semistructured interviews of primary caregivers were performed. From April to October 2003, 121 children were enrolled; 39 HIV-infected, 40 HIV-affected, and 42 control children with a median age of 9.3 years. The HIV-infected group had a mean (standard deviation [SD]) CD4 percentage of 13.8% (5.3), 87% of whom had been receiving ART for a median of 35 weeks. At the first cognitive assessment, the mean (SD) of full-scale intelligence quotient (FSIQ) was 79 (13) and 88 (10) among HIV-infected and HIV-affected children, which was statistically lower than that of the control group at 96 (13; pâ<â0.01). The proportion of children with average intelligence level (FSIQâ>â90) among 3 groups were 21%, 49%, and 76%, respectively (pâ<â0.01). At 30 months of follow-up, the HIV-infected group had a mean (SD) CD4 percentage of 25.6% (5.6); 77% had undetectable viral load. The mean (SD) FSIQ of children among three groups were 75 (12), 85 (12), and 91 (12), respectively. Compared with the baseline assessment, the verbal scale score significantly decreased in all groups, including the controls, whereas the performance scales did not change. In conclusion, school-aged HIV-infected children have lower cognitive function than HIV-affected and normal children. Cognitive function was not improved after receiving ART. Further study to address whether early ART can preserve cognitive functioning among HIV-infected children should be explored
Recommended from our members
Adverse Pregnancy Outcomes Among Women Who Conceive on Antiretroviral Therapy
Adverse pregnancy outcomes for women who conceive on antiretroviral therapy (ART) may be increased, but data are conflicting.
Human immunodeficiency virus-infected, nonbreastfeeding women with pre-ART CD4 counts â„400 cells/ÎŒL who started ART during pregnancy were randomized after delivery to continue ART (CTART) or discontinue ART (DCART). Women randomized to DCART were recommended to restart if a subsequent pregnancy occurred or for clinical indications. Using both intent-to-treat and as-treated approaches, we performed Fisher exact tests to compare subsequent pregnancy outcomes by randomized arm.
Subsequent pregnancies occurred in 277 of 1652 (17%) women (CTART: 144/827; DCART: 133/825). A pregnancy outcome was recorded for 266 (96%) women with a median age of 27 years (interquartile range [IQR], 24-31 years) and median CD4+ T-cell count 638 cells/ÎŒL (IQR, 492-833 cells/ÎŒL). When spontaneous abortions and stillbirths were combined, there was a significant difference in events, with 33 of 140 (23.6%) in the CTART arm and 15 of 126 (11.9%) in the DCART arm (relative risk [RR], 2.0 [95% confidence interval {CI}, 1.1-3.5]; P = .02). In the as-treated analysis, the RR was reduced and no longer statistically significant (RR, 1.4 [95% CI, .8-2.4]).
Women randomized to continue ART who subsequently conceived were more likely to have spontaneous abortion or stillbirth, compared with women randomized to stop ART; however, the findings did not remain significant in the as-treated analysis. More data are needed on pregnancy outcomes among women conceiving on ART, particularly with newer regimens
Hospitalization and Mortality among HIV-Infected Children after Receiving Highly Active Antiretroviral Therapy
Alcohol use, suicidality and virologic nonâsuppression among young adults with perinatally acquired HIV in Thailand: a crossâsectional study
Abstract Introduction Young adults with perinatally acquired HIV (YAâPHIV) are facing transitions to adult life. This study assessed health risk behaviours (including substance use), mental health, quality of life (QOL) and HIV treatment outcomes of Thai YAâPHIV. Methods A crossâsectional study was conducted in Thai YAâPHIV aged 18â25 years who were enrolled in a prospective cohort study at five tertiary paediatric HIV care centres in Thailand. Study data were obtained through faceâtoâface interviews from November 2020 to July 2021. Assessments were performed for alcohol use (Alcohol Use Disorders Identification Test; AUDIT), smoking (Fagerstrom Test for Nicotine Dependence), drug/substance use (Drug Abuse Screening Test; DASTâ10), depression (Patient Health Questionnaire for Adolescents; PHQâA), anxiety (Generalized Anxiety Disorder; GADâ7) and QOL (World Health Organization QOL BriefâThai). HIV treatment outcomes were extracted from the National AIDS Program database. Results Of 355 YAâPHIV, 163 (46%) were males: their median age was 21.7 (interquartile range, IQR 20.2â23.5) years. There were 203 YAâPHIV (58%) who reported ever having sex; 141 (40%) were sexually active in the past 6 months, of whom 86 (61%) reported 100% condom use. Overall, 49 (14%) met the criteria for harmful alcohol use; 28 (7.9%) were alcohol dependent. Sixty (17%) were current smokers and 37 (11%) used drugs/substances. The frequency of moderate up to severe symptoms for depression was 18% and for anxiety was 9.7%. Their overall QOL was good in 180 (51%), moderate in 168 (47%) and poor in five (1.4%). There were 49 YAâPHIV (14%) with CD4 200 copies/ml). On multivariate analyses, the highest education at the primary to high school or vocational school levels (adjusted odds ratio [aOR] 2.02, 95% CI 1.40â3.95, p 0.04), harmful alcohol use (aOR 2.48, 95% CI 1.24â4.99, p 0.01), alcohol dependence (aOR 3.54, 95% CI 1.51â8.31, p <0.01) and lifetime suicidal attempt (aOR 2.66, 95% CI 1.11â6.35, p 0.03) were associated with nonâsuppression. Conclusions Regular screening for alcohol use and mental health, including suicidality, would be useful to identify YAâPHIV who need more intensive psychosocial support or referral services to ensure they can achieve and maintain a high QOL into adult life